SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-19-005256
Filing Date
2019-03-19
Accepted
2019-03-19 14:49:15
Documents
79
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K dffn20181231_10k.htm 10-K 1702718
2 EXHIBIT 3.1 ex_137220.htm EX-3.1 31986
3 EXHIBIT 21.1 ex_137086.htm EX-21.1 5061
4 EXHIBIT 23.1 ex_137221.htm EX-23.1 3542
5 EXHIBIT 31.1 ex_137083.htm EX-31.1 15107
6 EXHIBIT 31.2 ex_137084.htm EX-31.2 14428
7 EXHIBIT 32.1 ex_137085.htm EX-32.1 5356
14 kpmgsig.jpg GRAPHIC 2562
15 dffn20181231_10kimg004.jpg GRAPHIC 28630
16 dffn20181231_10kimg003.jpg GRAPHIC 9717
17 dffn20181231_10kimg002.jpg GRAPHIC 14380
18 chart02.jpg GRAPHIC 160392
  Complete submission text file 0001437749-19-005256.txt   6233613

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT dffn-20181231.xml EX-101.INS 901279
9 XBRL TAXONOMY EXTENSION SCHEMA dffn-20181231.xsd EX-101.SCH 58546
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20181231_cal.xml EX-101.CAL 39664
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20181231_def.xml EX-101.DEF 417861
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20181231_lab.xml EX-101.LAB 364477
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20181231_pre.xml EX-101.PRE 447065
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37942 | Film No.: 19691211
SIC: 2834 Pharmaceutical Preparations